This is a preview of subscription content, log in via an institution to check access.
References
NICE. NICE says yes to eye condition treatment in final guidance. Media Release : 22 Oct 2013. Available from: URL: http://www.nice.org.uk
NICE. NICE says yes to new prostate cancer drug. Media Release : 16 Oct 2013. Available from: URL: http://www.nice.org.uk
Rights and permissions
About this article
Cite this article
NICE `yes' for ocriplasmin and enzalutamide. PharmacoEcon Outcomes News 690, 11 (2013). https://doi.org/10.1007/s40274-013-0845-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0845-0